SouthernBiotech

Executive Summary

SouthernBiotech is a privately held biotechnology company based in Birmingham, Alabama, founded in 1982. With over four decades of experience, the company has established itself as a reliable supplier of high-quality antibodies, immunoassays, and related reagents for biomedical research and diagnostic applications. Its core strengths lie in secondary antibodies, custom antibody services, and a broad portfolio of immunoreagents that support drug discovery and diagnostics. SouthernBiotech serves academic, pharmaceutical, and diagnostic customers globally, leveraging its manufacturing expertise and quality control to maintain a reputation for consistency and performance. As a private entity without disclosed funding rounds or valuation, the company appears to operate as a stable, self-sustaining business focused on niche reagent supply rather than high-growth therapeutic development. Its long-standing presence and specialized catalog suggest steady demand from the research community, though the lack of public financials or major partnerships limits visibility into growth trajectory. The company remains a quiet but established player in the antibody market, competing with larger vendors through customization and technical support.

Upcoming Catalysts (preview)

• TBDLaunch of next-generation custom antibody services with faster turnaround70% success
• TBDExpansion into diagnostic assay kits for emerging biomarkers50% success
• TBDStrategic partnership with a pharmaceutical company for immunoreagent supply40% success